Athira Pharma, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
LeonaBio amends its S-1 filing to register 5.5 million common shares for resale by Sermonix Pharmaceuticals, Inc., generating minimal proceeds for LeonaBio from warrant exercise.
LeonaBio, a clinical-stage biopharmaceutical company, filed an S-1/A to register 58.5 million shares for resale by existing stockholders, with potential proceeds of $146 million from warrant exercises for company operations.